The evidence base for tirzepatide as monotherapy is robust, with pivotal trials including SURMOUNT-1 demonstrating significant weight reduction in adults with obesity, and SURPASS trials establishing glycemic efficacy in type 2 diabetes
Start with 0.5-1mg daily if injecting, or a 1-2% topical product applied once daily
Regrowth Serum This guide breaks down the key differences between MDhair's copper peptide and biotinoyl peptide formulas
Injections, on the other hand, offer a more direct and potent alternative
However, not all people with B12 deficiency have the same number, variety or severity of symptoms
Long-Term Data: While short-to-medium term studies (up to several months) indicate safety, long-term safety data (over multiple years) in broad populations is still being gathered